Gilberto Schwartsmann

10.3k citations
269 papers · 8.4k · 2 hit papers · h-index 44

Impact in

  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Global Cancer Incidence and Screening
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 11
    • Peptidase Inhibition and Analysis 11
    • Colorectal Cancer Treatments and Studies 10
    • Global Cancer Incidence and Screening 9
    • Neuropeptides and Animal Physiology 49

Gilberto Schwartsmann

262 papers receiving 8.0k citations

Gilberto Schwartsmann's Hit Papers

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial 2015 · 943 citations
9430+4+8Years since publication250500750

Peers

Gilberto Schwartsmann
Comparison fields: 5 of 159
  • Oncology 2.5k
  • Cancer Research 837
  • Toxicology 178
  • Cellular and Molecular Neuroscience 928
  • Physiology 220
Replace Scott Arthur Waldman with:
Scott Arthur Waldman United States
Benjamin K. Tsang Canada
Anthony J. Murgo United States
Jilly F. Evans United States
Mario Del Tacca Italy
Li Li China
Sebastiano Andò Italy
Michael J. Reed United Kingdom
Matthew M. Ames United States
Yong‐Yeon Cho South Korea
Gilberto Schwartsmann relative to Scott Arthur Waldman United States Scott Arthur Waldman's profile →
Citations per field
00.5×1.5×
Scott Arthur Waldman · 1×
Citations per year

Countries citing papers authored by Gilberto Schwartsmann

Since Specialization
Citations

This map shows the geographic impact of Gilberto Schwartsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilberto Schwartsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilberto Schwartsmann more than expected).

Fields of papers citing papers by Gilberto Schwartsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilberto Schwartsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilberto Schwartsmann. The network helps show where Gilberto Schwartsmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Gilberto Schwartsmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilberto Schwartsmann Line = papers co-authored together Gilberto Schwartsmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Hit paper breakdown →
2015943
2
Planning cancer control in Latin America and the Caribbean
Hit paper breakdown →
2013412
3 2001223
4 2000206
5 2007204
6 2008156
7
Anticancer drug discovery and development throughout the world.
2002129
8 2002124
9 2008114
10 2000105
11 2007102
12 199396
13 199993
14 199990
15 201690
16 200389
17
Breast cancer in South America: challenges to improve early detection and medical management of a public health problem.
200184
18 200684
19
In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.
199078
20 200278

About Gilberto Schwartsmann

Gilberto Schwartsmann is a scholar working on Oncology, Cellular and Molecular Neuroscience, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 269 papers that have together received 8.4k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (49 papers), Cancer therapeutics and mechanisms (20 papers), Histone Deacetylase Inhibitors Research (12 papers), Cancer Treatment and Pharmacology (11 papers), Peptidase Inhibition and Analysis (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Global Cancer Incidence and Screening (9 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (837 citations), Toxicology (178 citations), Cellular and Molecular Neuroscience (928 citations) and Physiology (220 citations). Gilberto Schwartsmann has collaborated with scholars based in Brazil, United States and Netherlands. Frequent co-authors include Rafael Roesler, Adriana Brondani da Rocha, Dennis R.A. Mans, Caroline Brunetto de Farias, Ana Lúcia Abujamra, João Antônio Pêgas Henriques, Algemir Lunardi Brunetto, Daniel C. Damin, Ivana Grivicich and José María Jimeno. Their work appears in journals such as Annals of Oncology, Peptides, European Journal of Cancer, Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact